3291-46-1

Basic information

• Product Name: (2S,3S)-diethyl oxirane-2,3-dicarboxylate
• CAS NO: 3291-46-1
• Molecular Weight: 188.18
• Mol File: 3291-46-1.mol
• Article Data: 21

Chemical Properties

• CAS DataBase Reference: (2S,3S)-diethyl oxirane-2,3-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S)-diethyl oxirane-2,3-dicarboxylate(3291-46-1)
• EPA Substance Registry System: (2S,3S)-diethyl oxirane-2,3-dicarboxylate(3291-46-1)

Safety Data

• Hazardous Substances Data: 3291-46-1(Hazardous Substances Data)

Usage

General Description

(2S,3S)-diethyl oxirane-2,3-dicarboxylate is a chemical compound with the molecular formula C8H12O6. It is also known by the systematic name diethyl (2S,3S)-2,3-epoxybutane-1,4-dicarboxylate. (2S,3S)-diethyl oxirane-2,3-dicarboxylate is a diester derived from oxirane and dicarboxylic acid. It is commonly used as an intermediate in organic synthesis to create other compounds, such as pharmaceuticals, agrochemicals, and fragrances. The (2S,3S) configuration indicates that the two chiral centers in the molecule have a specific 3-dimensional arrangement, which can impact its reactivity and biological activity. The compound's properties and potential applications make it a valuable building block in chemical and pharmaceutical industries.

Upstream product

• 623-91-6 diethyl Fumarate 
• 691-84-9 Diethyl (S)-malate 
• 57968-71-5 (+/-)-diethyl tartrate 
• 13811-71-7 diethyl (2S,3S)-tartrate 
• 64-17-5 ethanol 
• 141-36-6 DL-trans-epoxysuccinic acid 
• 80640-15-9 diethyl (2S,3R)-(+)-erythro-2-hydroxy-3-bromosuccinate 
• 93713-32-7 (+)-(2S,3S)-trans-Oxiran-2,3-dicarbonsaeure-L-Arginin-Salz 
• 17087-75-1 (-)-trans-2,3-oxiranedicarboxylic acid 
• 1520-50-9 but-2-enedioic acid diethyl ester 
• 188944-76-5 2-Bromo-3-hydroxy-succinic acid diethyl ester 

Downstream Products

• 68362-57-2 C₆H₇ClO₄ 
• 63734-73-6 ethyl (2S,3S)-3-carboxylate oxirane-2-carboxylic acid 
• 141-05-9 Diethyl maleate 
• 623-91-6 diethyl Fumarate 
• 17087-75-1 (-)-trans-2,3-oxiranedicarboxylic acid 
• 1448429-21-7 (2S,3S)-ethyl-3-((S)-1-oxo-1-((1-(4-(piperidin-1-ylsulfonyl)phenyl)-1H-1,2,3-triazol-4-yl)methylamino)-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-20-6 (2S,3S)-ethyl-3-((S)-1-((1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl)methylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-19-3 (2S,3S)-ethyl-3-((S)-1-oxo-1-(1-phenyl-1H-1,2,3-triazol-4-yl)methylamino-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-48-8 (2S,3S)-ethyl 3-((S)-1-(4-(4-fluorophenyl)thiazol-2-ylamino)-3-(1-methyl-1H-imidazol-4-yl)-1-oxopropan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-47-7 (2S,3S)-ethyl 3-((S)-1-(4-(4-fluorophenyl)thiazol-2-ylamino)-3-(1-methyl-1H-imidazol-5-yl)-1-oxopropan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-46-6 (2S,3S)-ethyl 3-((S)-1-(4-(4-ethynylphenyl)thiazol-2-ylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-45-5 (2S,3S)-ethyl 3-((S)-1-(4-(4-fluorophenyl)thiazol-2-ylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-44-4 (2S,3S)-ethyl 3-((S)-1-oxo-1-(phenylamino)-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-40-0 (2S,3S)-ethyl 3-(1-(4-(4-fluorophenyl)thiazol-2-ylamino)-3-(1H-imidazol-4-yl)-1-oxopropan-2-ylcarbamoyl)oxirane-2-carboxylate 

Relevant articles and documents

Approaching an experimental electron density model of the biologically active trans-epoxysuccinyl amide group—Substituent effects vs. crystal packing

The trans-epoxysuccinyl amide group as a biologically active moiety in cysteine protease inhibitors such as loxistatin acid E64c has been used as a benchmark system for theoretical studies of environmental effects on the electron density of small active i

2,3-EPOXY SUCCINYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USES THEREOF

The present invention relates to a 2,3-epoxy succinyl derivative, a preparation method and a use thereof, in particular, the present invention relates to a compound represented by Formula (1), a racemate or an optical isomer thereof, a solvate thereof, or

2, 3-Butanediamide Epoxide Compound and Preparation Method and Use Thereof

Provided are a compound of formula I which can be used as a drug against small RNA virus infections, and optical isomers, pharmaceutically acceptable salts, solvates or hydrates thereof. Also provided are the preparation method of the compound, the method for using the compound for treating bacterial infections and the use of the compound in the preparation of a drug for preventing and/or treating viral diseases caused by small RNA viruses.